Formation Bio

The shift in pharma’s go-to-market models driven by the growing relevance of a personalized, data-driven approach, the need for ambidextrous leadership and learnings from Amazon, Netflix and Ikea were

Biopharmaceutical venture capital fundraising is on the rise in 2024, boosted in part by surging numbers of $100m-plus mega-rounds, including a pair of large financings that ended June and started Jul